Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jeremy C. Smith, University of Heidelberg Introduction to Protein Simulations and Drug Design R P.

Similar presentations


Presentation on theme: "Jeremy C. Smith, University of Heidelberg Introduction to Protein Simulations and Drug Design R P."— Presentation transcript:

1 Jeremy C. Smith, University of Heidelberg Introduction to Protein Simulations and Drug Design R P

2 Universität Heidelberg Computational Molecular Biophysics The Boss

3 Protein Folding and Structure. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g., ion transport, light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association. Some Problems to be Solved

4

5 Computer Simulation - Basic Principles Molecular Mechanics Potential Model System Quantum Mechanical Molecular Mechanical or QM/MM Potential Simulation - exploring the energy landscape

6 Normal Mode Analysis (Jianpeng Ma) Molecular Dynamics (Bert de Groot/Phil Biggin) Minimum-Energy Pathways Some Simulation Methods

7 Protein Folding and Structure. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g., ion transport, light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.

8 Protein Folding Funnel

9 Protein Folding 1) What structure does a given sequence have? - comparative modelling - energy-based (´ab initio´)? - data-base based (´knowledge´)? 2) How does a protein fold? …..computer simulation?….

10 Bundeshochleistungsrechner Hitachi SR8000-F1

11 Protein Folding Exploring the Folding Landscape (Johan Åqvist Free Energy Calculations) ANDREEA GRUIA

12 Safety in Numbers

13

14 Substrate Protein Ligand BINDING REACTION FUNCTION STRUCTURAL CHANGE

15 Protein Folding. Protein Structure. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g.ion transport,light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.

16 QM/MM - (Gerrit Groenhof/Ursula Rothlisberger) Model System Quantum Mechanical Molecular Mechanical Reactant Product

17 ATP Hydrolysis by Myosin SONJA SCHWARZL

18 Protein Folding. Protein Structure. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g.ion transport,light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.

19 Charge Transfer in Biological Systems Membranes and Membrane Proteins Light-Driven (Excited States)? (Gerrit Groenhof) Electron Transfer (Excited States?) Ion Transfer (H +,K +,Cl - ) Molecule Transfer (H 2 O) (Bert de Groot)

20 Halorhodopsin - Chloride Pumping at Atomic Resolution ANDREEA GRUIA

21

22 Protein Folding. Protein Structure. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g.ion transport,light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.

23 Molecular Dynamics Simulation Experiment Simplified Description (Wilfred van Gunsteren)

24 The Protein Glass Transition d d n n Onset of Protein Function

25 Mode Incipient at Myoglobin Glass Transition ALEX TOURNIER

26 Protein Folding. Protein Structure. Self-Assembly of Biological Structures. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g.ion transport,light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.

27 Power Stroke in Muscle Contraction.

28 Protein Folding. Protein Structure. Self-Assembly of Biological Structures. Enzyme Reaction Mechanisms. Bioenergetic Systems e.g.ion transport,light-driven. Protein Dynamics and Relation to Function. Large-Scale Conformational Change. Ligand Binding and Macromolecular Association.  Drug Design

29 High Throughput Screening  10 4 ligands per day  Drug Design But: Hit Rate 10 -6 per ligand

30

31 Drug Design Finding the Right Key for the Lock William Lipscomb: Drug design for Diabetes Type II

32 Is the structure of the target known?

33 Ligands Trypsin Target

34 Protein Ligand Complex Ligand Binding. Two Approaches: 1) Binding Free Energy Calculations 2) Empirical Scoring Functions

35 What is the binding free energy? ligand protein complex water polar and non-polar interactions with the solvent polar and non-polar protein-ligand interactions entropic effects k1k1 k -1 FRAUKE MEYER

36 Electrostatics: Thermodynamic Cycle + +

37 Methods flexibility (Jon Essex) MD (Daan van Aalten) scoring functions, virtual screening (Martin Stahl, Qi Chen) prediction of active sites (Gerhard Klebe) active site homologies

38 Fast Calculation of Absolute Binding Free Energies: Interaction of Benzamidine Analogs with Trypsin Benzamidine-like Trypsin InhibitorsEnergy Terms and Results - van der Waals protein:ligand - hydrophobic effect (surface area dependent) - electrostatic interactions (continuum approach) - translational, rotational, vibrational degrees of freedom SONJA SCHWARZL STEFAN FISCHER

39 Detection of Individual p53- Autoantibodies in Human Sera Cancer Biotechnology. ANDREA VAIANA MARKUS SAUER JUERGEN WOLFRUM ANDREAS SCHULTZ

40 RHF 6-31G* basis set R6G ab initio structure

41 MR121 Fluorescence Quenching of Dyes by Trytophan Dye Quencher

42 Fluorescently labeled Peptide ?

43 Analysis r

44

45 Strategy: QuenchedFluorescent Results: Healthy Person Serum Cancer Patient Serum

46 Things to learn (if you don´t know them already) 1) Which different angles can my problem be approached from? (talk to people from different fields). 2) Can I bring a new angle to someone else´s apparently very unrelated problem? 3) Where are the information sources? 4) ´Do not respect professors´ (question them)

47


Download ppt "Jeremy C. Smith, University of Heidelberg Introduction to Protein Simulations and Drug Design R P."

Similar presentations


Ads by Google